Načítá se...
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Immune-checkpoint inhibitors and chimeric antigen receptor (CAR) T cells are revolutionizing oncology and haematology practice. With these and other immunotherapies, however, systemic biodistribution raises safety issues, potentially requiring the use of suboptimal doses or even precluding their cli...
Uloženo v:
| Vydáno v: | Nat Rev Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130796/ https://ncbi.nlm.nih.gov/pubmed/34006998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-021-00507-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|